文献速递神经肌肉病

血清脂质与肌萎缩侧索硬化患者生存的关联:一项Meta分析与基于人群的研究

Association Between Serum Lipids and Survival in Patients With Amyotrophic Lateral Sclerosis: A Meta-analysis and Population-Based Study.
PubMed 文献 · Neurology · 2022-12-02

该研究通过Meta分析4项研究并结合荷兰连续诊断的1,324例肌萎缩侧索硬化患者数据,评估血脂、脂质代谢生物标志物的多基因谱评分与疾病严重程度及生存的关系。Meta分析显示脂质代谢生物标志物与总生存均无统计学显著关联但异质性较大;个体数据显示高密度脂蛋白胆固醇升高与更差生存相关(HR 1.33,95%CI 1.14-1.55,p<0.001),总胆固醇和低密度脂蛋白胆固醇在更晚期临床阶段更低。

要点

  • Meta分析4项研究显示脂质代谢生物标志物与总生存均无统计学显著关联,但研究间异质性较大。
  • 1,324例患者个体数据显示高密度脂蛋白胆固醇升高与更差生存相关(HR 1.33,95%CI 1.14-1.55,p<0.001)。
  • 总胆固醇和低密度脂蛋白胆固醇在更晚期临床阶段更低(均p<0.001)。

核心结论

  • 脂质可能包含关于疾病严重程度和预后的有价值信息,但其主要价值可能由疾病进展驱动。
  • 研究结果强调,进一步了解脂质代谢及血清脂质谱的纵向数据可改善患者监测并可能进一步阐明肌萎缩侧索硬化的发病机制。

研究设计与样本

  • 研究对当前关于脂质在肌萎缩侧索硬化患者中预后价值的文献进行了Meta分析。
  • 随后评估了荷兰所有连续诊断患者诊断时血脂水平、临床疾病分期与生存的关系,个体患者数据N=1,324。
  • 计算每种脂质与总生存的风险比(HR),总生存定义为任何原因死亡。
  • 一部分患者与既往全基因组关联研究匹配,用于计算脂质代谢生物标志物的多基因谱评分(PPS)并确定诊断时观察到的血脂水平与生存的关联。

主要发现

  • 4项研究的Meta分析表明,脂质代谢生物标志物均与总生存无统计学显著关联,但研究结果间存在相当大的异质性。
  • 在1,324例个体患者数据中,高密度脂蛋白(HDL)胆固醇升高与更差生存相关(HR 1.33,95%CI 1.14-1.55,p<0.001)。
  • BMI与HDL胆固醇呈负相关(Pearson r -0.26,95%CI -0.32至-0.20),BMI与甘油三酯(TG)呈正相关(Pearson r 0.18,95%CI 0.12-0.24)。
  • 总胆固醇和低密度脂蛋白胆固醇的血清浓度在更晚期临床阶段更低(均p<0.001)。
  • 脂质代谢生物标志物的PPS解释了诊断时其变异的1.2%-13.1%,但所有PPS均与生存无显著关联(均p>0.50)。

局限性

  • Meta分析纳入的4项研究结果间存在相当大的异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: To explore the association between lipids, polygenic profile scores (PPS) for biomarkers of lipid metabolism, markers of disease severity, and survival in patients with amyotrophic lateral sclerosis (ALS). METHODS: We meta-analyzed the current literature on the prognostic value of lipids in patients with ALS. Subsequently, we evaluated the relationship between lipid levels at diagnosis, clinical disease stage, and survival in all consecutive patients diagnosed in the Netherlands. We determined the hazard ratio (HR) of each lipid for overall survival, defined as death from any cause. A subset of patients was matched to a previous genome-wide association study; data were used to calculate PPS for biomarkers of lipid metabolism and to determine the association between observed lipid levels at diagnosis and survival. RESULTS: Meta-analysis of 4 studies indicated that none of the biomarkers of the lipid metabolism were statistically significantly associated with overall survival; there was, however, considerable heterogeneity between study results. Using individual patient data (N = 1,324), we found that increased high-density lipoprotein (HDL) cholesterol was associated with poorer survival (HR of 1.33 (95% CI 1.14-1.55, p < 0.001)). The correlation between BMI and HDL cholesterol (Pearson r -0.26, 95% CI -0.32 to -0.20) was negative and between BMI and triglycerides (TG) positive (Pearson r 0.18, 95% CI 0.12-0.24). Serum concentrations of total cholesterol and LDL cholesterol were lower in more advanced clinical stages (both p < 0.001). PPS for biomarkers of lipid metabolism explained 1.2%-13.1% of their variance at diagnosis. None of the PPS was significantly associated with survival (all p > 0.50). DISCUSSION: Lipids may contain valuable information about disease severity and prognosis, but their main value may be driven as a consequence of disease progression. Our results underscore that gaining further insight into lipid metabolism and longitudinal data on serum concentrations of the lipid profile could improve the monitoring of patients and potentially further disentangle ALS pathogenesis.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Janse van Mantgem MR, van Rheenen W, Hackeng AV, et al. Association Between Serum Lipids and Survival in Patients With Amyotrophic Lateral Sclerosis: A Meta-analysis and Population-Based Study. Neurology. 2022. PMID: 36460467. doi:10.1212/WNL.0000000000201657

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。